← Browse by Condition
Medical Condition

atypical fibroxanthoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06239272 Phase 1, Phase 2
Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Enrollment
139 pts
Location
United States
Sponsor
St. Jude Children's Research H...
View Trial →